168 related articles for article (PubMed ID: 17855634)
1. Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia.
Rawat VP; Thoene S; Naidu VM; Arseni N; Heilmeier B; Metzeler K; Petropoulos K; Deshpande A; Quintanilla-Martinez L; Bohlander SK; Spiekermann K; Hiddemann W; Feuring-Buske M; Buske C
Blood; 2008 Jan; 111(1):309-19. PubMed ID: 17855634
[TBL] [Abstract][Full Text] [Related]
2. Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine model.
Bansal D; Scholl C; Fröhling S; McDowell E; Lee BH; Döhner K; Ernst P; Davidson AJ; Daley GQ; Zon LI; Gilliland DG; Huntly BJ
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16924-9. PubMed ID: 17068127
[TBL] [Abstract][Full Text] [Related]
3. HOX gene regulation in acute myeloid leukemia: CDX marks the spot?
Fröhling S; Scholl C; Bansal D; Huntly BJ
Cell Cycle; 2007 Sep; 6(18):2241-5. PubMed ID: 17881901
[TBL] [Abstract][Full Text] [Related]
4. HOX deregulation in acute myeloid leukemia.
Rice KL; Licht JD
J Clin Invest; 2007 Apr; 117(4):865-8. PubMed ID: 17404613
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia.
Rawat VP; Cusan M; Deshpande A; Hiddemann W; Quintanilla-Martinez L; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
Proc Natl Acad Sci U S A; 2004 Jan; 101(3):817-22. PubMed ID: 14718672
[TBL] [Abstract][Full Text] [Related]
6. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
Wang GG; Pasillas MP; Kamps MP
Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
[TBL] [Abstract][Full Text] [Related]
7. The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis.
Scholl C; Bansal D; Döhner K; Eiwen K; Huntly BJ; Lee BH; Rücker FG; Schlenk RF; Bullinger L; Döhner H; Gilliland DG; Fröhling S
J Clin Invest; 2007 Apr; 117(4):1037-48. PubMed ID: 17347684
[TBL] [Abstract][Full Text] [Related]
8. CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
Faber K; Bullinger L; Ragu C; Garding A; Mertens D; Miller C; Martin D; Walcher D; Döhner K; Döhner H; Claus R; Plass C; Sykes SM; Lane SW; Scholl C; Fröhling S
J Clin Invest; 2013 Jan; 123(1):299-314. PubMed ID: 23202735
[TBL] [Abstract][Full Text] [Related]
9. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
[TBL] [Abstract][Full Text] [Related]
10. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
11. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes.
Palmqvist L; Pineault N; Wasslavik C; Humphries RK
PLoS One; 2007 Aug; 2(8):e768. PubMed ID: 17712416
[TBL] [Abstract][Full Text] [Related]
12. Beyond Hox: the role of ParaHox genes in normal and malignant hematopoiesis.
Rawat VP; Humphries RK; Buske C
Blood; 2012 Jul; 120(3):519-27. PubMed ID: 22547580
[TBL] [Abstract][Full Text] [Related]
13. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
[TBL] [Abstract][Full Text] [Related]
14. Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3.
Argiropoulos B; Palmqvist L; Yung E; Kuchenbauer F; Heuser M; Sly LM; Wan A; Krystal G; Humphries RK
Exp Hematol; 2008 Jul; 36(7):845-59. PubMed ID: 18375036
[TBL] [Abstract][Full Text] [Related]
15. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
Pineault N; Abramovich C; Ohta H; Humphries RK
Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
[TBL] [Abstract][Full Text] [Related]
16. HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL.
Starkova J; Zamostna B; Mejstrikova E; Krejci R; Drabkin HA; Trka J
Pediatr Blood Cancer; 2010 Dec; 55(6):1072-82. PubMed ID: 20672366
[TBL] [Abstract][Full Text] [Related]
17. Modulation of murine embryonic stem cell-derived CD41+c-kit+ hematopoietic progenitors by ectopic expression of Cdx genes.
McKinney-Freeman SL; Lengerke C; Jang IH; Schmitt S; Wang Y; Philitas M; Shea J; Daley GQ
Blood; 2008 May; 111(10):4944-53. PubMed ID: 18252864
[TBL] [Abstract][Full Text] [Related]
18. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia.
Palmqvist L; Argiropoulos B; Pineault N; Abramovich C; Sly LM; Krystal G; Wan A; Humphries RK
Blood; 2006 Aug; 108(3):1030-6. PubMed ID: 16861351
[TBL] [Abstract][Full Text] [Related]
19. [Expression level of CDX2 gene in acute myeloid leukemia and its clinical significance].
Lu Y; Wang Q; Mu QT; Yu MX; Chen ZM; Lou JY; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):835-8. PubMed ID: 23384906
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of HHEX in Acute Myeloid Leukemia with t(8;21)(q22;q22) Translocation.
Zhang S; Ma L; Chen Y; Xu H; Chen S; Wu W
Ann Clin Lab Sci; 2017 Nov; 47(6):687-697. PubMed ID: 29263042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
